[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

NCT07662759 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

188

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma Open-Angle Primary
Ocular Hypertension

Interventions

DRUG: TFC-003
DRUG: TFC-003-R1
DRUG: TFC-003-R2+TFC-003-R3

Sponsor

Kukje Pharma